Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
FANGZHOU Aktie jetzt für 0€ handeln | |||||
26.09. | Fangzhou Inc.: Fangzhou's 'XingShi' LLM Featured by Nature News and Xinhua, Showcasing AI Innovation in Chronic Disease Care | 1 | GlobeNewswire (USA) | ||
25.09. | FANGZHOU JIANKE (06086): 2025 INTERIM REPORT | - | HKEx | ||
18.09. | Fangzhou Inc.: Fangzhou Named 'Outstanding Growth Story in Hong Kong Stocks' at China Capital Market Development Forum 2025 | 1 | GlobeNewswire (USA) | ||
18.09. | Fangzhou Inc.: Fangzhou Wins Gilead 'Award of Excellence' for AI-Driven Chronic Disease Management | 13 | GlobeNewswire (USA) | ||
15.09. | FANGZHOU JIANKE (06086): ANNOUNCEMENT MADE PURSUANT TO RULE 13.10 OF THE LISTING RULES | - | HKEx | ||
14.09. | Fangzhou Inc.: Fangzhou Unveils "XingShi" LLM to Advance AI-Driven Chronic Disease Management | 2 | GlobeNewswire (USA) | ||
10.09. | Fangzhou Inc.: Fangzhou and Innovent Biologics Form Strategic Alliance for AI-Powered Weight Management Solutions | 324 | GlobeNewswire (Europe) | SHANGHAI, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, signed a strategic partnership with Innovent... ► Artikel lesen | |
03.09. | Fangzhou Inc.: Fangzhou Secures 2nd National Science Foundation Project Approval, Deepens AI-Driven Healthcare Research | 2 | GlobeNewswire (USA) | ||
27.08. | Fangzhou Inc.: Fangzhou Posts Strong 1H Revenue and Profit as Physician Network and User Base Expand | 324 | PR Newswire | HONG KONG, Aug. 27, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, reported... ► Artikel lesen | |
27.08. | FANGZHOU JIANKE (06086): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 | 3 | HKEx | ||
15.08. | FANGZHOU JIANKE (06086): DATE OF BOARD MEETING | - | HKEx | ||
21.07. | Fangzhou and Novo Nordisk link on chronic disease management | 44 | Pharmaceutical Technology | ||
21.07. | Fangzhou And Novo Nordisk Collaborate To Combat Chronic Diseases | 45 | RTTNews | ||
18.07. | Novo Nordisk, Fangzhou Partner to Tackle Chronic Diseases | 58 | Mexico Business News | ||
18.07. | Fangzhou Inc.: Fangzhou and Novo Nordisk Signed Collaboration Memorandum to Establish a New Ecosystem for Health Management | 429 | PR Newswire | BEIJING, July 18, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum... ► Artikel lesen | |
19.06. | FANGZHOU JIANKE (06086): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON THURSDAY, JUNE 19, 2025 | 1 | HKEx | ||
18.06. | FANGZHOU JIANKE (06086): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE | 1 | HKEx | ||
18.06. | FANGZHOU JIANKE (06086): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | - | HKEx | ||
18.06. | FANGZHOU JIANKE (06086): APPOINTMENT OF MEMBER OF THE NOMINATION COMMITTEE | - | HKEx | ||
27.05. | FANGZHOU JIANKE (06086): INVITATION LETTER TO REGISTERED SHAREHOLDERS FOR ONLINE ATTENDANCE AT 2025 ANNUAL GENERAL MEETING | 1 | HKEx |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PRIVIA HEALTH GROUP | 24,460 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Second Quarter 2025 Financial Results | Very Strong First Half Performance Across All Key Operating and Financial MetricsImplemented Providers +13.8% and Practice Collections +18.5% compared to 2Q'24Guidance Raised to Above High End of... ► Artikel lesen | |
GENEDX | 117,37 | 0,00 % | GeneDx announces first genomic newborn screening initiative | ||
PROCEPT BIOROBOTICS | 34,800 | 0,00 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 47,100 | +0,40 % | SIEMENS HEALTHINEERS versucht die Börsenpräsenz zu erweitern | SIEMENS ist bereit, bis 51 % zu reduzieren. Das ergäbe ein Emissionsvolumen von geschätzt 17 bis 18 Mrd. € gegenüber dem aktuellen Stand. Aus München verlautet, dass es dafür kein Börsenkonsortium gibt... ► Artikel lesen | |
FRESENIUS | 47,100 | +0,19 % | ROUNDUP/Aktien Frankfurt Schluss: Dax setzt wieder zurück - Richtungssuche | FRANKFURT (dpa-AFX) - Nach den leichten Gewinnen am Vortag hat der Dax am Donnerstag wieder den Rückwärtsgang eingelegt. Als Belastung für die hiesigen Börsen erwiesen sich zeitweise vor allem die... ► Artikel lesen | |
GERRESHEIMER | 37,100 | +1,37 % | Gerresheimer, dynaCERT, Volkswagen - Spannende Entwicklungen! | Nachrichten machen Kurse. Das Pendel kann aber in beide Richtungen schwingen. Für informierte Anleger ist die richtige Interpretation der Ereignisse von entscheidender Bedeutung. Oft ergeben sich dann... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 16,045 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health Unveils 2026 Medicare Advantage Plans with Strong Benefits, Expanded Support for Seniors | ORANGE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage (MA) plan from Alignment Health, today announced its 2026 product portfolio, offering 68... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 28,730 | 0,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 45,360 | -0,29 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
HEARTFLOW | 36,140 | 0,00 % | HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis | ||
BETA BIONICS | 20,490 | 0,00 % | Forecasting The Future: 4 Analyst Projections For Beta Bionics | ||
AIRSCULPT TECHNOLOGIES | 7,960 | 0,00 % | Airsculpt Technologies, Inc.: AirSculpt Technologies Reports First Quarter Fiscal 2025 Results and Full Year Guidance | MIAMI BEACH, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen | |
MIMEDX | 6,710 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results | Highest Quarterly Net Sales in MIMEDX History Second Quarter Net Sales of $99 million Grew 13% Year-Over-Year Second Quarter GAAP Net Income and Diluted Earnings Per Share were $10 Million and $0.06... ► Artikel lesen | |
RXSIGHT | 8,560 | 0,00 % | Pre-market Movers: Basel Medical Group, SOBR Safe, ProKidney, RxSight, Mustang Bio | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green Basel Medical Group Ltd (BMGL) is up over 88% at... ► Artikel lesen | |
PROGYNY | 20,540 | 0,00 % | A Healthcare Debate: Progyny vs. Hims & Hers |